tert-butyl 4-(N-methylbenzo[d][1,3]dioxole-5-carboxamido)piperidine-1-carboxylate

Catalog No.: 
ACJUFA178
CAS No.: 
1420994-53-1
Molecular Formula: 
C19H26N2O5
Molecular Weight: 
362.43
tert-butyl 4-(N-methylbenzo[d][1,3]dioxole-5-carboxamido)piperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-butyl 4-(N-methylbenzo[d][1,3]dioxole-5-carboxamido)piperidine-1-carboxylate
IUPAC Nametert-butyl 4-(N-methylbenzo[d][1,3]dioxole-5-carboxamido)piperidine-1-carboxylate
Molecular FormulaC19H26N2O5
Molecular Weight362.43
SMILESCN(C(=O)C1=CC2=C(C=C1)OCO2)C1CCN(C(=O)OC(C)(C)C)CC1
InChI KeyIHBBOKDYWHKDLF-UHFFFAOYSA-N
Synonym1-Piperidinecarboxylic acid, 4-[(1,3-benzodioxol-5-ylcarbonyl)methylamino]-, 1,1-dimethylethyl ester
CAS No.1420994-53-1

Synthetic Route by SureRoute

1. ACJUFA178 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHDRZ650 route compound structure diagram
    ACHDRZ650147539-41-1In Stock
  2. Plus
  3. ACKQGR750 route compound structure diagram
    ACKQGR75094-53-1In Stock
  4. Then
  5. ACJUFA178 route product structure diagram
    ACJUFA1781420994-53-1
Inquiry

2. ACJUFA178 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHDRZ650 route compound structure diagram
    ACHDRZ650147539-41-1In Stock
  2. Plus
  3. ACWUCN419 route compound structure diagram
    ACWUCN41925054-53-9In Stock
  4. Then
  5. ACJUFA178 route product structure diagram
    ACJUFA1781420994-53-1
Inquiry

3. ACJUFA178 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJUFA178 route product structure diagram
    ACJUFA1781420994-53-1
Inquiry

Comments (0)